Giovanni Mauri - 预约 - GSD - 意大利医院集团

个人简介

Giovanni Mauri 教授是介入放射科医生，现任 IRCCS Galeazzi-Sant’Ambrogio 医院诊断与介入放射科中影像引导下甲状腺微创治疗研究实验室负责人，同时担任米兰大学影像诊断与放射治疗副教授。

他于2007年毕业于米兰大学，并于2012年在同一大学获得放射诊断学专科资格。2010年，他在伦敦大学圣乔治医院担任介入放射学临床研究员（Clinical Fellow）。2011年，他在美国波士顿哈佛医学院布莱根妇女医院（Brigham and Women’s Hospital）担任研究员（Research Fellow）。2019年至2022年，他在米兰大学担任研究员。自2026年起，他担任米兰大学影像诊断与放射治疗副教授。

他的主要研究领域包括影像引导下的微创治疗和介入放射学操作，特别专注于热消融治疗技术。

2023年至2025年，他担任欧洲心血管与介入放射学会（CIRSE）甲状腺微创治疗工作组主席。他是“termoablazione.expert” 项目的发起人和负责人，该项目旨在推广热消融技术的相关知识，同时也是“意大利甲状腺微创治疗研究组（MITT）”的创始人。

他是欧洲甲状腺肿瘤微创治疗指南的作者之一，迄今已在国内外学术期刊发表204篇论文，H指数为42，并在国内外课程及学术会议上进行了200余场报告。

多媒体中心

Thermal ablation of kidney tumors: the minimally invasive alternative to traditional surgery at Galeazzi-Sant’Ambrogio

出版物

最新出版物

European Thyroid Association and Cardiovascular and Interventional Radiological Society of Europe 2021 Clinical Practice Guideline for the Use of Minimally Invasive Treatments in Malignant Thyroid Lesions

Eur Thyroid J. 2021 10 (3), pp. 185-197. DOI: 10.1159/000516469

Mauri, G., Hegedüs, L., Bandula, S., Cazzato, R.L., Czarniecka, A., Dudeck, O., Fugazzola, L., Netea-Maier, R., Russ, G., Wallin, G., Papini, E.

Image-guided thermal ablation in autonomously functioning thyroid nodules. A retrospective multicenter three-year follow-up study from the Italian Minimally Invasive Treatment of the Thyroid (MITT)

Group Eur Radiol 2022 32 (3), pp. 1738-1746. DOI: 10.1007/s00330-021-08289-8

Mauri, G., Papini, E., Bernardi, S., Barbaro, D., Cesareo, R., De Feo, P., Deandrea, M., Fugazzola, L., Gambelunghe, G., Greco, G., Messina, C., Monti, S., Mormile, A., Negro, R., Offi, C., Palermo, A., Persani, L., Presciuttini, F., Solbiati, L.A., Spiezia, S., Stacul, F., Viganò, M., Sconfienza, L.M.

Minimally-invasive treatments for benign thyroid nodules: recommendations for information to patients and referring physicians by the Italian Minimally

Invasive Treatments of the Thyroid group Endocrine 2022, 76 (1), DOI: 10.1007/s12020-022-03005-y

Mauri, G., Bernardi, S., Palermo, A., Cesareo, R., Papini, E., Solbiati, L., Barbaro, D., Monti, S., Deandrea, M., Fugazzola, L., Gambelunghe, G., Negro, R., Spiezia, S., Stacul, F., Sconfienza, L.M., Cavallaro, M., Achille, G., Cantisani, V., Cozzaglio, L., Crescenzi, A., De Cobelli, F., Garberoglio, R., Giugliano, G., Persani, L., Raggiunti, B., Seregni, E., Van Doorne, D., Frasoldati, A., Carzaniga, C., Lombardi, C.P., Papi, G., Guglielmi, R., Orsi, F., Cervelli, R., Barbieri, C., Trimboli, P., Monzani, D. the Italian Minimally-Invasive Treatments of the Thyroid group.

Image-Guided Thyroid Ablation: Proposal for Standardization of Terminology and Reporting Criteria

Thyroid. 2019 May;29(5):611-618. DOI: 10.1089/thy.2018.0604.

Mauri G, Pacella CM, Papini E, Solbiati L, Goldberg SN, Ahmed M, Sconfienza LM.

Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group

Int J Hyperthermia. 2019;36(1):376-382. DOI: 10.1080/02656736.2019.1575482.

Papini E, Pacella CM, Solbiati LA, Achille G, Barbaro D, Bernardi S, Cantisani V, Cesareo R, Chiti A, Cozzaglio L, Crescenzi A, De Cobelli F, Deandrea M, Fugazzola L, Gambelunghe G, Garberoglio R, Giugliano G, Luzi L, Negro R, Persani L, Raggiunti B, Sardanelli F, Seregni E, Sollini M, Spiezia S, Stacul F, Van Doorne D, Sconfienza LM, Mauri G.

Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a feasibility study. Results at 6 and 12 months from a retrospective multi-centric study

Prostate Cancer Prostatic Dis. 2019 Dec 11. DOI: 10.1038/s41391-019-0196-4.

Pacella CM, Patelli G, Iapicca G, Manenti G, Perretta T, Ryan CP, Esposito R, Mauri G.

Efficacy of thermal ablation in benign non-functioning solid thyroid nodule: A systematic review and meta-analysis

Endocrine. 2020; 67(1):35-43. Jul 20. DOI: 10.1007/s12020-019-02019-3.

Trimboli P, Castellana M, Sconfienza LM, Virili C, Pescatori LC, Cesareo R, Giorgino F, Negro R, Giovanella L, Mauri G.

Long-Term Follow-Up Outcomes after Percutaneous US/CT-Guided Radiofrequency Ablation for cT1a-b Renal Masses: Experience from Single High-Volume Referral Center

Cancers Cancers 2020 37 (1), pp. 660-667. DOI: 10.1080/02656736.2020.1778801

Mauri G, Mistretta FA, Bonomo G, Camisassi N, Conti A, Della Vigna P, Ferro M, Luzzago S, Maiettini D, Musi G, Piacentini N, Varano GM, de Cobelli O, Orsi F.

Real-Time US-CT fusion imaging for guidance of thermal ablation in of renal tumors invisible or poorly visible with US: results in 97 cases

Int J Hyperthermia 2021, 38 (1), pp. 771-776. DOI: 10.1080/02656736.2021.1923837

Mauri, G., Monfardini, L., Della Vigna, P., Montano, F., Bonomo, G., Buccimazza, G., Camisassi, N., Rossi, D., Maiettini, D., Varano, G.M., Solbiati, L., Orsi, F.

Present Status of Thyroid Ablation in Europe: An International Survey among the Cardiovascular and Interventional Radiological Society of Europe (CIRSE)

Members Cardiovasc Intervent Radiol 2022 45 (9), pp. 1385-1390. DOI: 10.1007/s00270-022-03231-x

Mauri, G., Monfardini, L., Lucertini, E., Cazzato, R.L., Pereira, P., Orsi, F., Sconfienza, L.M.